Interview with Diana Valencia, Executive Director, LatAm Clinical Trials
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Address: Av. 9 No. 123-86 / Of. 703 Bogotá D.C. Colombia
Tel: (571) 6203530
Web: http://www.latamtrials.com/
Latam Clinical Trials specializes in conducting superior Phase I-IV clinical trials in Latin America, specifically in the Andean Region, Central America and the Caribbean, offering our three services lines: Conducting and Monitoring Clinical trials, Management of Regulatory Issues, and training.
Latam Clinical Trials has business development offices in the USA and clinical staff located in the Andean Countries of South America and in Central America, giving access to substantial underutilized medical expertise and infrastructure throughout an area that includes Ecuador, Colombia, Peru, Panama and Venezuela.
Latam Clinical Trials’ geographic reach is extended to additional countries in Latin America through partnerships with other local CROs in Mexico, Argentina and Brazil
Regulatory Support and Submission, Patient Recruitment Management, Project Management
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Francisco Rossi, Director of Colombia’s National Food and Drug Surveillance Institute (INVIMA), discusses the agency’s ongoing transformation to become a faster, more transparent, and globally recognised regulator. Since his return…
At its recent assembly in Bogotá, ALIFAR – the Latin American Association of National Pharmaceutical Industries – brought together chambers from 14 countries to set a shared agenda for 2025.…
Clara Isabel Rodríguez, Executive Director of the Colombian Association of the Pharmaceutical Industry (ASCIF), shares her journey from public sector leadership to industry advocacy. With deep experience in health regulation…
Yaneth Giha, Executive Director of FIFARMA, has transformed the organisation from a traditional trade association into a strategic platform for advancing healthcare access in Latin America. The first woman to…
Tecnoquímicas recently invested over USD 250 million in its Colombian manufacturing plants, signifying the company’s continuing faith in its home market. Executive Vice-President Emilio Sardi Aparicio outlines the regulatory and…
Latin America is renowned for its creative geniuses – think footballers like Lionel Messi and Pelé; magical realist authors such as Gabriel García Márquez and Isabel Allende; and ground-breaking artists…
Yaneth Giha of FIFARMA – the leading association for the innovative pharmaceutical industry in Latin America – gives a bird’s-eye overview on some of the key trends in LatAm healthcare,…
The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced OTC product boom; Faes Farma’s growth; and why prostate…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion pharma market, announced a swathe of manufacturing investments in late 2019, taking its spending on plants and equipment in…
With the onset of universal public healthcare, new types of foreign actors have been spying fresh opportunities to penetrate the Colombian market. Inward investment from India, in particular, has been…
With Latin America’s best healthcare system in terms of both coverage and quality, Colombia is fast becoming a destination of choice for multinationals, not only to set up shop in…
Sandra Ramirez, General Manager of Bristol-Myers Squibb Colombia & Mexico, reveals valuable insights into the long-standing presence of BMS in Colombia, marked by a continuous dedication to increase access to…
See our Cookie Privacy Policy Here
